Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
ExcelCSVXML     print

13Gérard Siest

 

Key Opinion Leader In [Gérard Siest is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 10Lipids | 13Apolipoproteins E | 24France | 45Cholesterol, HDL | 59Polymorphism, Genetic | 75Triglycerides | 83Cohort Studies | 239Genotype | 693Adolescent

Keywords (32) [keywords assigned to Gérard Siest articles by PubMed, the leading number and the color conveys importance]

  • 12Humans | 9Male | 8Female | 7Adult | 6Cohort Studies | 6Polymorphism, Genetic | 5Adolescent | 5Middle Aged | 5France | 4Apolipoproteins E | 4Child | 4Genotype | 4Lipids | 3Triglycerides | 3Cholesterol, HDL | 3Child, Preschool | 3Aged | 3Risk Factors | 2Phenotype | 2Cholesterol | 2Peroxidase | 2Antioxidants | 2Reference Values | 2Aryldialkylphosphatase | 2Genetic Predisposition to Disease | 2Smoking | 2Polymerase Chain Reaction | 1Inflammation Mediators | 1Hyperlipoproteinemia Type II | 1Glutathione Peroxidase | 1Sodium Chloride | 1Intercellular Adhesion Molecule-1

Other [context-specific ads]

Gérard Siest Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gérard Siest might be a good expert witness on these terms]

  • 17polymorphism | 16mpo | 16study | 15serum | 14paraoxonase | 13stanislas | 13cohort | 12factors | 11allele | 11risk | 11polymorphisms | 11phenotype | 10association | 10vitamin | 10cardiovascular | 10apoc-iii | 9height | 9genotype | 9g-463a | 9subjects | 9associated | 9concentration | 8activities | 7aging | 7ad | 7selenium | 7alcohol | 7drugs | 6within | 6population | 6familial | 6supplementation
  • 13stanislas cohort | 8apoc-iii concentration | 6g-463a polymorphism | 6serum apoc-iii | 5risk factors | 4cardiovascular risk | 4retinol alpha-tocopherol | 4paraoxonase arylesterase | 4alcohol rehabilitation | 4salt-stimulated paraoxonase | 4genotype assessments | 4mpo polymorphisms | 3functional outcome | 3aging indicator | 3apoeurope study | 3vitamin carotenoids | 3subjects stanislas | 3height cardiovascular | 3allele g-463a | 3atherosclerosis risk | 3zinc selenium | 3slow h-components | 3apoe phenotype | 3oral contraceptive | 3glutathione peroxidase | 3factors reference | 3phenotype genotype | 3reference intervals | 3lipoprotein lipase | 3alzheimer disease | 3cardiovascular drugs | 3lipid response
  • 5serum apoc-iii concentration | 3phenotype genotype assessments | 3oral contraceptive intake | 3cardiovascular risk factors | 3subjects stanislas cohort | 3height cardiovascular risk | 3allele g-463a polymorphism | 2apolipoproteins solution lipid-bound | 2effect six candidate | 2supplementation alcohol rehabilitation | 2disease apoeurope study | 2xinc selenium micronutrient | 2time-dependent lipid response | 2hypercholesterolemia sensitive apoe | 2salt-stimulated paraoxonase arylesterase | 2candidate genes early | 2vitamin carotenoids xinc | 2infarct size functional | 2carotenoids xinc selenium | 2solution lipid-bound form | 2fluvastatin therapy patients | 2paraoxonase polymorphism codon | 2pharmacogenomics drugs affecting | 2early aging french | 2patients hypercholesterolemia sensitive | 2peroxidase activities stanislas | 2aging french population | 2cohort influencing factors | 2micronutrient supplementation alcohol | 2polymorphism alzheimer disease | 2superoxide dismutase whole-blood | 2exchangeable apolipoproteins solution